57-88-5 (胆固醇,Cholesterol)

胆固醇;胆固醇,参比液;胆固醇,标准液;(3β)-胆甾-5-烯-3-醇;胆甾-5-烯-3β-醇;胆脂醇;异辛甾烯醇;胆甾醇;胆甾烷醇;胆固烯醇;Cholesterol (stabilized with alpha-Tocopherol) 胆固醇;胆固醇 Cholesterol;胆固醇 EP标准品;胆固醇 标准品;胆固醇,Merck;胆固醇,半合成品;胆固醇,对照品;胆固醇纯度标准物质;胆甾-5-烯3β醇;高纯胆固醇;实验专用胆固醇;胆固;胆固醇,Cholesterol,AR;胆固醇纯度标准物质;胆甾醇;胆甾醇烷;异辛甾烯醇;胆固烯醇;胆脂醇;胆脂素;胆脂素醇;左旋倍他洛尔;合成胆固醇;胆固醇素;胆甾烷醇 (含稳定剂α-生育酚);胆甾醇 (含稳定剂α-生育酚);Cholesterol 胆固醇 生物技术级;胆固醇 (-20℃);胆固醇/胆甾醇;

6-Cholesten-3b-ol;5-Cholesten-3beta-ol;cholesterol from lanolin;cholesterol from hog liver;Cholesterol, NF;(3beta)-cholest-5-en-3-ol;(3.beta.)-Cholest-5-en-3-ol;(3β)-cholest-5-en-3-ol;3β-hydroxycholest-5-ene;5,6-Cholesten-3beta-ol;5:6-cholesten-3-beta-ol;5:6-Cholesten-3beta-ol;5-Cholesten-3B-ol;5-cholesten-3β-ol;Cholest-5-en-3beta-ol;3beta-hydroxycholest-5-ene;3beta-hydroxy-5-cholestene;Cholesterol (stabilized with alpha-Tocopherol);Cholest-5-en-3-ol;Cholest-5-en-3β-ol;Cholesterol;CHOLESTEROL (AS);Cholesterol solution;Cholesterol, Semi-synthetic;20-Dihydro Cortexolone;20-Dihydro-11-deoxycortisol;3β-Hydroxy-5-cholestene;cholesterin;cholest-5-en-3β-ol ; 110796;cholest-5-en-3β-ol; 110797;CHO-HP;Cholesteryl alcohol;Cholestrin;Dusoline;Dusoran;Cordulan;Cholesterine;Cholestrol;Hydrocerin;Kathro;Dythol;Lanol;Super hartolan;Provitamin D;Cholesterol base H;Lidinite;Lidinit;Nimco cholesterol base H;Wool alcohols B. P.;(-)-Cholesterol;Tegolan (VAN);Cholest-5-en-3-beta-ol;Tegolan;Cholest-5-en-3-ol (3beta)-;3-beta-Hydroxycholest-5-ene;Dataset-S1.258;34026-89-6;57-88-5;(3beta,14beta,17alpha)-cholest-5-en-3-ol;5:6-Cholesten-3-ol;NSC-8798;Cholesterol, Vetec(TM) reagent grade, >=92.5%;epicholesterin;3.beta.-Hydroxycholest-5-ene;AB00443913_03;20bFH-cholest-5-en-3b-ol;CHOLESTEROL [JAN];Tox21_111595;delta(sup 5)-Cholesten-3-beta-ol;CHOLESTEROL [VANDF];Q43656;(3H)-Cholesterol;CAS-57-88-5;CHOLESTEROL (USP-RS);Cholesterol, 99.0%;5-Cholesten-3ss--ol;Cholesterol, European Pharmacopoeia (EP) Reference Standard;CHOLESTEROL [WHO-DD];Cholest-5-en-3-ol (3beta)-, labeled with tritium;Cholesterol1551;Cholesterol, from lanolin, >=95.0% (GC);WLN: L E5 B666 LUTJ A1 E1 FY1&3Y1&1 OQ;DB04540;BIDD:PXR0095;CHOLESTEROL (MART.);(+)-ent-Cholesterol;NCGC00159351-03;Soya phospholipon & Cholesterol (2:1 molar ratio);3beta-cholest-5-en-3-ol;CHOLESTEROL (II);D00040;AKOS005267135;GTPL2718;cholest-5-en-3b-ol;W-105431;80356-14-5;CS-1096707;CHEBI:140435;F70214;Epitope ID:150761;Cholesterol 10 microg/mL in Acetonitrile;CHOLESTEROL [MI];Cholesterol,(S);Liquid crystal CN/9;CHOLESTEROL [USP-RS];CHOLESTEROL (EP MONOGRAPH);Cholesterol, Pharmaceutical Secondary Standard; Certified Reference Material;DTXCID402401;5BBA213B-ECF4-44AF-8AAF-8A0120F2F886;CHOLESTEROL [EP MONOGRAPH];Cholesterol [BAN:JAN:NF];EN300-323186;Cholesterol (TN);LMST01010001;Cholesterol (Excipient);.DELTA.5-Cholesten-3-.beta.-ol;Cholest-5-en-3-ol, (3.beta.)- #;CHEBI:16113;CHOLESTEROL [MART.];AI3-03112;Dastar;NSC8798;Cholesterinum;CHOLESTEROL [II];Phospholipon & Cholesterol;Analytical Reagent,>95.0%(HPLC);s4154;3h-cholesterol;CMC_13392;5,6-Cholesten-3.beta.-ol;ALFQ component cholesterol;Cholest-5-en-3-ol (3.beta.)-;HSDB 7106;Fancol CH;20-epi-cholesterol;Cholesterol, tested according to Ph.Eur.;Cholesterol, from lanolin, >=99.0% (GC);Cholesterol, powder, BioReagent, suitable for cell culture, >=99%;BIDD:ER0548;Cholesterol, United States Pharmacopeia (USP) Reference Standard;(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadec-7-en-5-ol;SMP1_000069;129111-15-5;Z2033589790;C00187;Cholesterol (>99%);Cholest-5-en-3-ol (3beta);3ss--Hydroxy-5-cholestene;1zhy;Cholest-5-en-3-ol, (3-.beta.)-;BP-26125;(1R,3aS,3bS,7S,9aR,9bS,11aR)-9a,11a-dimethyl-1-[(2R)-6-methylheptan-2-yl]-1H,2H,3H,3aH,3bH,4H,6H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-ol;Cholest-5-en-3-ol, (3beta)-;NCGC00159351-02;C3624;CCRIS 2834;CHEMBL112570;CHOLESTEROL (IARC);BDBM20192;10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol;HY-N0322;(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;Cholesterol (JP18/NF);EC 200-353-2;CHOLESTEROL [HSDB];Army Liposome Formulation component cholesterol;ALF component cholesterol;CHOLESTEROL [IARC];GS-6857;Cholesterol-t;Provitamin-d;Cholesterol, 94%;5-cholestene-3beta-ol;Cholesterol, >=95% (GC), powder, Ash, free;EINECS 200-353-2;Nimco cholesterol base No. 712;5-Cholesten-3.beta.-ol;Delta5-Cholesten-3beta-ol;CS-5106;NSC 8798;(3S,8S,9S,10R,13R,14S,17R)-17-[(1R)-1,5-dimethylhexyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol;(20bFH)-cholest-5-en-3b-ol;97C5T2UQ7J;Cholesterol?;(3b)-cholest-5-en-3-ol;UNII-97C5T2UQ7J;CHOLESTERINUM [HPUS];HY-N0322B;NS00005787;MFCD00003646;(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol;DTXSID3022401;22243-67-0;20-iso-cholesterol;Cholesterol, NIST(R) SRM(R) 911c;5:6-Cholesten-3.beta.-ol;Cholesterol, Sigma Grade, >=99%;Cholest-5-en-3.beta.-ol;

MFCD00003646

HVYWMOMLDIMFJA-DPAQBDIFSA-N

1S/C27H46O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h9,18-19,21-25,28H,6-8,10-17H2,1-5H3/t19-,21+,22+,23-,24+,25+,26+,27-/m1/s1

O([H])[C@@]1([H])C([H])([H])C([H])([H])[C@@]2(C([H])([H])[H])C(C1([H])[H])=C([H])C([H])([H])[C@]1([H])[C@]2([H])C([H])([H])C([H])([H])[C@]2(C([H])([H])[H])[C@@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])C([H])([H])[C@]21[H]

1915888

2834

2906131000

2060565

1915888